NUK - logo
E-viri
Celotno besedilo
Recenzirano
  • Ren, Li; Wenglowsky, Steve; Miknis, Greg; Rast, Bryson; Buckmelter, Alex J; Ely, Robert J; Schlachter, Stephen; Laird, Ellen R; Randolph, Nikole; Callejo, Michele; Martinson, Matthew; Galbraith, Sarah; Brandhuber, Barbara J; Vigers, Guy; Morales, Tony; Voegtli, Walter C; Lyssikatos, Joseph

    Bioorganic & medicinal chemistry letters, 2011-Feb-15, 20110215, Letnik: 21, Številka: 4
    Journal Article

    The development of inhibitors of B-Raf(V600E) serine-threonine kinase is described. Various head-groups were examined to optimize inhibitor activity and ADME properties. Several of the head-groups explored, including naphthol, phenol and hydroxyamidine, possessed good activity but had poor pharmacokinetic exposure in mice. Exposure was improved by incorporating more metabolically stable groups such as indazole and tricyclic pyrazole, while indazole could also be optimized for good cellular activity.